Artemis Global Life Sciences (Delisted) financials and balance sheet

BSE: 540616

Last traded ₹49.45 on 23 Oct 2019

Delisted on 27 May 2020.

2 years at a glance

Consolidated: the company and its subsidiaries together. ₹ crore, years to March.Artemis Global Life Sciences annual reports

Revenue, net profit and borrowings, ₹ crore

  • Revenue
  • Net profit
  • Borrowings
Peak revenue ₹547 Cr, year to Mar 2019

Operating and net margin, per cent

  • Operating margin
  • Net margin

Results for the year to Mar 2019

Consolidated: the company and its subsidiaries together. ₹ crore.

From revenue to net profit

  1. Revenue547
  2. Materials and goods−131
  3. Employee costs−97
  4. Other expenses−255
  5. Operating profit64
  6. Depreciation−20
  7. Other income+4.0
  8. One-off items0.0
  9. Finance costs−11
  10. Profit before tax37
  11. Tax−16
  12. Net profit20

What the company owns

  • Plant, investments and other assets₹456 Cr
  • Receivables₹79 Cr
  • Cash and bank₹12 Cr
  • Inventory₹7 Cr

What pays for it: net worth and liabilities

  • Net worth₹293 Cr
  • Other liabilities₹96 Cr
  • Borrowings₹91 Cr
  • Owed to suppliers₹74 Cr

Profit and loss

Consolidated, ₹ crore, years to March.Artemis Global Life Sciences quarterly results

₹ croreMar 2018Mar 2019Filed 13 May
Revenue from operations503547
444483
Materials and goods bought1131
Employee costs–97
Other expenses–255
Operating profit before depreciation5964
Operating margin11.7%11.7%
Materials, % of revenue–23.9%
Employee costs, % of revenue–17.8%
Other expenses, % of revenue–46.6%
Depreciation and amortisation1920
Operating profit after depreciation4044
Other income44
Finance costs911
Profit before one-off items and tax3537
One-off items00
Profit before tax3537
916
2620
Other comprehensive income–0
Total comprehensive income–20
Net margin5.2%3.7%
Materials, employee costs and other expenses are shown for the years they add up to operating expenses; for the year to Mar 2018 they do not, so they are left blank.

Balance sheet

Consolidated, ₹ crore, at 31 March.

₹ croreMar 2019Filed 13 May
293
293
Share capital13
Reserves280
Belonging to outside owners of subsidiaries0
91
177
84
Total assets554
442
113
Net debt79
Borrowings are counted again inside the liabilities due within a year and after a year. No balance sheet is on record for the year to Mar 2018, so its lines and the ratios worked from it are blank there.

Per share

Consolidated, ₹ per share, years to March.

₹ per shareMar 2018Mar 2019Filed 13 May
Earnings per share₹3.97₹3.10
Diluted earnings per share₹3.97₹3.10
Book value per share–₹44.34
Market cap at the year end (₹ crore)–398

Ratios

Consolidated, years to March.

RatioMar 2018Mar 2019Filed 13 May
Revenue growth–8.7%
Operating profit growth–8.3%
Net profit growth–−22.4%
Earnings per share growth–−21.9%
Return on equity–7.0%
Return on capital employed–11.4%
Interest cover4.34.0
Debt to equity–0.31
Receivable days–53
Inventory days–19
Payable days–206
Cash conversion cycle, days–−134
Working capital days–−26
Asset turnover–0.99
Assets per rupee of net worth–1.89
Sales per rupee of plant–1.63
Plant being built, % of plant in use–14.8%
No balance sheet is on record for the year to Mar 2018, so its lines and the ratios worked from it are blank there.

Growth and returns over 3, 5 and 10 years

Consolidated: the company and its subsidiaries together. Each window ends with the year to Mar 2019.

Return on assets, latest year
3.7%
Measure3 years
Operating margin, average11.7%
Net margin, average4.5%
Interest cover, average4.1

Accounting checks

Consolidated, years to March. Published tests of whether reported profit is backed by cash and the balance sheet.

CheckMar 2018Mar 2019
Altman Z-scorePublished threshold 1.1–2.65
Effective tax ratePublished threshold 17.16 per cent24.7244.51
A threshold marked as ours has no published figure; it is the line we read the check against.